Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03124667 · ClinicalTrials.gov registry record · NA

Cognitive Regulation Training and Exercise Trial

A NA study of Patient Compliance, sponsored by University of Illinois at Urbana-Champaign.

Completed
Registry status
NA
Development phase
233
Enrollment target
1
Study location

NCT03124667: Completed NA study of Patient Compliance, sponsored by University of Illinois at Urbana-Champaign.

NCT03124667 is a NA study of Patient Compliance that has completed, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 233 participants, above the 95-participant average among 6 other Patient Compliance trials with a reported enrollment target (145% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03124667, a NA study of Patient Compliance, has completed, sponsored by University of Illinois at Urbana-Champaign.

COMPLETED
Registry status
NA
Development phase
233 participants
Enrollment target
1
Study location

Study Summary

The purpose of this double-blinded, randomized controlled study is to compare CORTEX (Cognitive Regulation Training and Exercise), a multi-faceted, center- and home-delivered- general and exercise-specific-active and traditional computerized cognitive training (CT) program to an attention-control condition involving health and wellness informational videos. More specifically, the cognitive training group will emphasize dual-task abilities, working memory, and visual-spatial processing, as well as self-as-exerciser priming and self-certainty training. It is hypothesized that early intervention cognitive training will enhance use of self-regulatory strategies and self-efficacy and in turn, increase exercise adherence to and engagement in a 12-month aerobic and resistive exercise program at a local fitness facility. More positive improvements in cognitive and psychosocial functioning among participants in the CORTEX condition (relative to the Video Attention-Control condition, i.e., health educational videos), are also expected immediately following the cognitive training, and across time. Expectancies and knowledge of study purpose (blinding integrity) will also be measured and used to statistically adjust for any training differences.

Primary Outcome

Exercise self-regulation will be modeled within a latent variable framework. The change factor will be reflected by accumulated supervised and unsupervised class participation rates, total electronically-recorded visitations, averaged monthly Fitbit-derived step counts, and self-reported leisure-time exercise (via Godin Leisure-Time Questionnaire). Measures will be standardized as z-scores. The latent factor model will be adjusted for known covariates (age, gender, education level, training comp

Conditions Studied

Interventions

  • BEHAVIORAL Games
  • BEHAVIORAL Videos

Study Locations (1)

Illinois

  • University of Illinois - Urbana

Trial Details

FieldValue
Enrollment Target 233 participants
Start Date 2017-01-01
Est. Completion 2020-10-10
Phase NA

What the finished NCT03124667 record still lists

NCT03124667 is an interventional study that assigns participants to a tested intervention. The registered 233 participants enrollment target is mid-sized for trials with a published cap, above the 95-participant average among 6 other Patient Compliance trials with a reported enrollment target (145% higher).

The record links to 1 condition, with Patient Compliance appearing as the primary indexed condition, and to 2 interventions - of which Games is the first listed.

NCT03124667 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT03124667 about?

NCT03124667 is a clinical study titled "Cognitive Regulation Training and Exercise Trial". The purpose of this double-blinded, randomized controlled study is to compare CORTEX (Cognitive Regulation Training and Exercise), a multi-faceted, center- and home-delivered- general and exercise-specific-active and traditional computerized cognitive training (CT) program to an attention-control co...

What is the current status of trial NCT03124667?

This trial is currently completed. It is a NA study. The enrollment target is 233 participants. The study started on 2017-01-01. Estimated completion is 2020-10-10.

What conditions does trial NCT03124667 study?

This clinical trial studies the following conditions: Patient Compliance.

What interventions are being tested in trial NCT03124667?

The interventions under investigation include: Games (BEHAVIORAL), Videos (BEHAVIORAL).

Who is sponsoring clinical trial NCT03124667?

This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03124667 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Patient Compliance

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06993844 · 233 participants · Phase 1

    Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

  • NCT07141706 · 233 participants · Phase 1

    A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors

  • NCT04942717 · 234 participants · NA

    Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values

  • NCT05208671 · 234 participants · NA

    Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for Oklahoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03124667, the US trial registry maintained by the National Library of Medicine. NCT03124667 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.